Literature DB >> 3994350

Activities of the modified polyene N-D-ornithyl amphotericin methyl ester and the azoles ICI 153066, Bay n 7133, and Bay l 9139 compared with those of amphotericin B and ketoconazole in the therapy of experimental blastomycosis.

E Lefler, E Brummer, A M Perlman, D A Stevens.   

Abstract

We studied the efficacy of new experimental antifungal drugs, which represent molecular modifications of present active agents, in a murine model of blastomycosis. Ketoconazole, previously the best azole drug studied and which is protective when administered orally, was superior to a new oral imidazole, Bay l 9139, and a new oral triazole, Bay n 7133. A new oral triazole, ICI 153066, was markedly more effective than ketoconazole and is the only oral drug studied which came close to producing complete sterilization of all visceral infection in all animals treated. Amphotericin B, a polyene given parenterally, was shown to be more efficacious than any drug studied. It completely sterilized the infection. A modified polyene, N-D-ornithyl amphotericin methyl ester, was only slightly less effective on a milligram-per-kilogram basis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3994350      PMCID: PMC176278          DOI: 10.1128/AAC.27.3.363

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Combined activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans in vitro and in vivo in mice.

Authors:  J D Hamilton; D M Elliott
Journal:  J Infect Dis       Date:  1975-02       Impact factor: 5.226

2.  In-vitro inhibitory activities of 2 new orally absorbable imidazole derivatives: BAY n 7133 and BAY 1 9139.

Authors:  R A Fromtling; H P Yu; S Shadomy
Journal:  Sabouraudia       Date:  1983-09

3.  Comparative chemotherapeutic activity of amphotericin B and amphotericine B methy ester.

Authors:  D P Bonner; R P Tewari; M Solotorovsky; W Mechlinski; C P Schaffner
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

4.  Study of current and new drugs in a murine model of acute paracoccidioidomycosis.

Authors:  E Lefler; E Brummer; J G McEwen; G L Hoyos; A Restrepo; D A Stevens
Journal:  Am J Trop Med Hyg       Date:  1985-01       Impact factor: 2.345

5.  Mouse model of pulmonary blastomycosis: utility, simplicity, and quantitative parameters.

Authors:  R P Harvey; E S Schmid; C C Carrington; D A Stevens
Journal:  Am Rev Respir Dis       Date:  1978-04

6.  Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size.

Authors:  J N Galgiani; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

7.  Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugs.

Authors:  D Borelli; J L Bran; J Fuentes; R Legendre; E Leiderman; H B Levine; A Restrepo; D A Stevens
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

8.  Treatment of experimental murine aspergillosis with BAY n7133.

Authors:  J R Graybill; S R Kaster; D J Drutz
Journal:  J Infect Dis       Date:  1983-11       Impact factor: 5.226

  8 in total
  7 in total

Review 1.  Murine models of blastomycosis, coccidioidomycosis, and histoplasmosis.

Authors:  K N Sorensen; K V Clemons; D A Stevens
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

Review 2.  Overview of medically important antifungal azole derivatives.

Authors:  R A Fromtling
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

3.  Comparative in vitro and in vivo evaluation of N-D-ornithyl amphotericin B methyl ester, amphotericin B methyl ester, and amphotericin B.

Authors:  R M Parmegiani; D Loebenberg; B Antonacci; T Yarosh-Tomaine; R Scupp; J J Wright; P J Chiu; G H Miller
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

4.  Effect of nystatin, amphotericin B and amphotericin B methyl ester on Saccharomyces cerevisiae with different lipid composition.

Authors:  M A de Resende; F Alterthum
Journal:  Mycopathologia       Date:  1990-12       Impact factor: 2.574

5.  Activity of ICI 195,739, a new oral triazole, compared with that of ketoconazole in the therapy of experimental murine blastomycosis.

Authors:  R M Tucker; L H Hanson; E Brummer; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

6.  Comparative efficacy of amphotericin B colloidal dispersion and amphotericin B deoxycholate suspension in treatment of murine coccidioidomycosis.

Authors:  K V Clemons; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

7.  Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis.

Authors:  J R Perfect; D T Durack
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.